• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

The $72 Million Talc Verdict Against J&J May Not Set a Precedent

By
Reuters
Down Arrow Button Icon
By
Reuters
Down Arrow Button Icon
February 26, 2016, 5:08 AM ET
LS010183
Photograph by Nancy R. Cohen — Getty Images

The $72 million verdict this week against Johnson & Johnson in a U.S. case alleging links between talc-based powder and ovarian cancer has prompted global headlines, social media buzz and calls to lawyers from would-be plaintiffs.

But the attention-grabbing judgment is no guarantee future plaintiffs will be able to convince juries the company’s products caused their illnesses.

About 1,200 similar cases are pending, primarily in Missouri and New Jersey state courts, but the facts are different in every one.

And even in cases with similar evidence and expert testimony, juries in mass personal-injury litigation can come to different conclusions.

While the survivors of Jacqueline Fox were awarded $72 million by a St. Louis jury Monday, jurors in a federal court action in South Dakota—the only other talc case to go to trial—found in 2013 that J&J (JNJ) had been negligent but declined to award damages to plaintiff Deane Berg.

Like Fox, Berg alleged her ovarian cancer was caused by her decades-long use of J&J’s talc-powder products for feminine hygiene, and jurors in both cases heard testimony about studies linking talc to cancer risks.

But, unlike Fox, who passed away several months before the trial began, Berg was in remission at the time of the trial, according to court documents.

In addition to factual differences among cases, venue can affect outcomes. Some state courts are considered more plaintiff-friendly than federal courts, which have stricter rules for the admission of evidence and expert testimony, said lawyers involved in the litigation.

One juror in the Missouri case, Jerome Kendrick, said in an interview with Reuters that he and other jurors were especially swayed by testimony from plaintiffs’ medical experts and documents showing J&J employees discussing talc powder’s possible cancer risk.

“The problem I had is that, according to inter office documents, J&J was aware of the potential concerns,” Kendrick said. “And it really looked like instead of trying to investigate, they started talking about how to combat what would eventually be a court case.”

J&J has said that “decades of sound science” prove that talc is safe. The company on Tuesday issued a statement expressing sympathy for Fox’s family but disagreeing with the verdict. It also said it is exploring its post-trial options.

Under the Radar

Talc litigation got its start in 2009, when Berg filed her lawsuit. The Fox lawsuit was selected by plaintiffs’ lawyers as the first to go to trial in Missouri, to serve as an early bellwether of how similar cases in that venue might fare.

The litigation flew largely under the public’s radar until jurors returned the award for the family of Fox, who died in October at 62. The plaintiffs said Fox used J&J Baby Powder and Shower to Shower Powder for feminine hygiene daily for 35 years before she was diagnosed three years ago with ovarian cancer.

It has resonated with the public far more than the Berg case, which “didn’t get headlines because they didn’t award any damages,” said R. Allen Smith, a Missouri-based lawyer who represented both the Fox family and Berg.

More cases may be filed soon, and lawyers at several plaintiffs’ firms who worked on the Fox case said they are investigating thousands of additional claims.

Still, the talc cases represent a relatively small portion of the tens of thousands of lawsuits J&J is facing over its many products. For instance, it is the target of more than 44,000 cases from women who say they were harmed by pelvic mesh devices made by its Ethicon unit, and more than 8,000 against its DePuy subsidiary regarding Pinnacle metal-on-metal hip systems.

The next J&J talc trial is set for April in St. Louis, and additional trial dates have been set for later this year.

To be successful, plaintiffs must make both a general link between talc and ovarian cancer and show that J&J’s products—as opposed to something else—are to blame for their cancer.

In spite of the increased interest in the litigation following the Fox verdict, attorney Danielle Mason of Beasley Allen, who was part of the team representing the Fox family at trial, said she expected J&J to fight hard to defend itself in upcoming trials. “We’re in this for the long haul,” she said.

About the Author
By Reuters
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Latest in Health

flu season
PoliticsFlu Season
You’re not just imagining it—this flu season is officially severe with 45 states reporting high or very high activity
By Mike Stobbe and The Associated PressJanuary 6, 2026
12 hours ago
rfk
PoliticsVaccines
America’s pediatricians reel as government slashes vaccine requirements for children
By Ali Swenson, Lauran Neergaard and The Associated PressJanuary 5, 2026
1 day ago
Travel & Leisurework-life balance
Experts are divided on how workers should spend their 5-9: Structure is key for productivity, but can lead to burnout
By Jamie Wilde and Morning BrewJanuary 5, 2026
1 day ago
trump
EnvironmentWhite House
‘I want nice, thin blood pouring through my heart'”: Trump talks health concerns, saying he takes more aspirin than recommended
By Michelle L. Price and The Associated PressJanuary 2, 2026
5 days ago
aca
PoliticsHealth Insurance
Millions of Americans start the new year with spiking health insurance costs under latest version of Obamacare
By Ali Swenson and The Associated PressJanuary 2, 2026
5 days ago
Person checking their phone in bed
Successlifestyle
Even top CEOs check their phones first thing in the morning—these are the apps business executives are reaching for
By Emma BurleighJanuary 2, 2026
5 days ago

Most Popular

placeholder alt text
Personal Finance
Janet Yellen warns the $38 trillion national debt is testing a red line economists have feared for decades
By Eva RoytburgJanuary 5, 2026
1 day ago
placeholder alt text
AI
Experienced software developers assumed AI would save them a chunk of time. But in one experiment, their tasks took 20% longer
By Sasha RogelbergJanuary 5, 2026
2 days ago
placeholder alt text
Success
Blackstone exec says elite Ivy League degrees aren’t good enough—new analysts need to 'work harder' and be nice 
By Ashley LutzJanuary 5, 2026
1 day ago
placeholder alt text
Personal Finance
Current price of silver as of Monday, January 5, 2026
By Joseph HostetlerJanuary 5, 2026
2 days ago
placeholder alt text
Energy
‘Big Short’ investor Michael Burry says toppling of Venezuela’s Maduro will weaken Russia’s global standing as its oil ‘just became less important’
By Marco Quiroz-GutierrezJanuary 5, 2026
1 day ago
placeholder alt text
Personal Finance
Current price of gold as of January 5, 2025
By Danny BakstJanuary 5, 2026
2 days ago